IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $339 | -23.3% | 21,362 | -8.8% | 0.00% | 0.0% |
Q2 2023 | $442 | +124.4% | 23,433 | -54.4% | 0.00% | +100.0% |
Q1 2023 | $197 | -21.8% | 51,401 | +1.3% | 0.00% | 0.0% |
Q4 2022 | $252 | -99.9% | 50,765 | -5.0% | 0.00% | 0.0% |
Q3 2022 | $256,000 | +6.2% | 53,463 | -0.2% | 0.00% | 0.0% |
Q2 2022 | $241,000 | +81.2% | 53,563 | +91.5% | 0.00% | 0.0% |
Q1 2022 | $133,000 | -35.7% | 27,974 | +0.4% | 0.00% | 0.0% |
Q4 2021 | $207,000 | +95.3% | 27,875 | +49.2% | 0.00% | 0.0% |
Q3 2021 | $106,000 | -5.4% | 18,687 | +7.6% | 0.00% | 0.0% |
Q4 2020 | $112,000 | +55.6% | 17,373 | -12.5% | 0.00% | – |
Q3 2020 | $72,000 | -20.9% | 19,866 | +0.5% | 0.00% | -100.0% |
Q2 2020 | $91,000 | +35.8% | 19,766 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $67,000 | -75.5% | 19,766 | +7.7% | 0.00% | -90.0% |
Q1 2014 | $274,000 | +21.2% | 18,358 | +19.1% | 0.01% | +11.1% |
Q4 2013 | $226,000 | -9.6% | 15,408 | +4.8% | 0.01% | -18.2% |
Q3 2013 | $250,000 | +8.2% | 14,708 | +5.8% | 0.01% | -8.3% |
Q2 2013 | $231,000 | – | 13,908 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
Grace Capital | 49,500 | $228,000 | 0.20% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |